Australian Clinical Labs (ASX:ACL) Price-to-Operating-Cash-Flow : 3.19 (As of May. 17, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Price-to-Operating-Cash-Flow?

As of today (2024-05-17), Australian Clinical Labs's share price is A$2.44. Australian Clinical Labs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.76. Hence, Australian Clinical Labs's Price-to-Operating-Cash-Flow Ratio for today is 3.19.

The historical rank and industry rank for Australian Clinical Labs's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:ACL' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.06 Med: 3.86 Max: 6.13
Current: 3.19

During the past 4 years, Australian Clinical Labs's highest Price-to-Operating-Cash-Flow Ratio was 6.13. The lowest was 2.06. And the median was 3.86.

ASX:ACL's Price-to-Operating-Cash-Flow is ranked better than
94.74% of 114 companies
in the Medical Diagnostics & Research industry
Industry Median: 18.295 vs ASX:ACL: 3.19

Australian Clinical Labs's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$0.37. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.76.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Australian Clinical Labs was -6.60% per year.

Australian Clinical Labs Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Australian Clinical Labs's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Price-to-Operating-Cash-Flow Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

3.36

3.26

4.82

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial			-	3.26	-	4.82	-

Competitive Comparison of Australian Clinical Labs's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Australian Clinical Labs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Australian Clinical Labs's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's Price-to-Operating-Cash-Flow falls into.

Australian Clinical Labs Price-to-Operating-Cash-Flow Calculation

Australian Clinical Labs's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	2.44	/	0.764
	=	3.19

Australian Clinical Labs's Share Price of today is A$2.44.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Australian Clinical Labs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.76.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Australian Clinical Labs Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines